145 related articles for article (PubMed ID: 2125039)
1. An antibody-tumor model for the targeting of CA125-producing gynecologic malignancies.
Saga T; Ishiwata I; Endo K; Sakahara H; Koizumi M; Watanabe Y; Nakai T; Hosono M; Ishikawa H; Sawada M
Jpn J Cancer Res; 1990 Nov; 81(11):1141-8. PubMed ID: 2125039
[TBL] [Abstract][Full Text] [Related]
2. Recognition of ovarian cancer antigen CA125 by murine monoclonal antibody produced by immunization of lung cancer cells.
Matsuoka Y; Nakashima T; Endo K; Yoshida T; Kunimatsu M; Sakahara H; Koizumi M; Nakagawa T; Yamaguchi N; Torizuka K
Cancer Res; 1987 Dec; 47(23):6335-40. PubMed ID: 3315184
[TBL] [Abstract][Full Text] [Related]
3. Construction of an immunoradiometric assay for ovarian cancer associated antigen CA125 recognizing different antigenic determinant.
Saga T; Endo K; Nakashima T; Awaji T; Koizumi M; Kawamura Y; Watanabe Y; Konishi J; Nonogaki H; Nanbu Y
Acta Obstet Gynecol Scand; 1990; 69(2):175-81. PubMed ID: 1696770
[TBL] [Abstract][Full Text] [Related]
4. Daunorubicin conjugated to a monoclonal anti-CA125 antibody selectively kills human ovarian cancer cells.
Sweet F; Rosik LO; Sommers GM; Collins JL
Gynecol Oncol; 1989 Sep; 34(3):305-11. PubMed ID: 2788601
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of new cancer-associated antigen CA125 II in epithelial ovarian cancers: comparison with CA125.
Kobayashi H; Tamura M; Satoh T; Terao T
Clin Biochem; 1993 Jun; 26(3):213-9. PubMed ID: 8330391
[TBL] [Abstract][Full Text] [Related]
6. [Basic study of CA125 measurement using a newly developed "SD-8729" IRMA kit].
Yamaguchi A; Kobayashi M; Imai T; Otake H; Matsubara K; Hatori N; Tomiyoshi K; Inoue T; Endo K
Kaku Igaku; 1993 Oct; 30(10):1245-52. PubMed ID: 8264116
[TBL] [Abstract][Full Text] [Related]
7. Characterization of CA125 glycoprotein using 3 monoclonal antibodies with different specificities.
Kobayashi F; Sagawa N; Fujii S; Mori T; Endo K
Gynecol Obstet Invest; 1994; 37(3):199-203. PubMed ID: 8005553
[TBL] [Abstract][Full Text] [Related]
8. A human/mouse chimeric monoclonal antibody against CA125 for radioimmunoimaging of ovarian cancer.
Kobayashi H; Sakahara H; Saga T; Hosono M; Shirato M; Kanda H; Ishibashi K; Watanabe T; Endo K; Ishiwata I
Cancer Immunol Immunother; 1993 Aug; 37(3):143-9. PubMed ID: 7687520
[TBL] [Abstract][Full Text] [Related]
9. Relationship of serum CA125 and lipid-associated sialic acid tumor-associated antigen levels to the disease status of patients with gynecologic malignancies.
Stratton JA; Rettenmaier MA; Phillips HB; Herabutya S; DiSaia PJ
Obstet Gynecol; 1988 Jan; 71(1):20-6. PubMed ID: 2827081
[TBL] [Abstract][Full Text] [Related]
10. Development of new immunoradiometric assay for CA 125 antigen using two monoclonal antibodies produced by immunizing lung cancer cells.
Kunimatsu M; Endo K; Nakashima T; Awaji T; Saga T; Watanabe Y; Kawamura Y; Ohta H; Koizumi M; Sakahara H
Ann Nucl Med; 1988 Nov; 2(2):73-9. PubMed ID: 3275111
[TBL] [Abstract][Full Text] [Related]
11. Human antibody response to the intravenous and intraperitoneal administration of the F(ab')2 fragment of the OC125 murine monoclonal antibody.
Maher VE; Drukman SJ; Kinders RJ; Hunter RE; Jennings J; Brigham C; Stevens S; Griffin TW
J Immunother (1991); 1992 Jan; 11(1):56-66. PubMed ID: 1734949
[TBL] [Abstract][Full Text] [Related]
12. [Heterogeneity of the CA125 antigen that coexpresses sialyl Tn and CA19-9 antigens].
Kobayashi H; Ohi H; Shinohara H; Terao T
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Sep; 45(9):980-6. PubMed ID: 8371024
[TBL] [Abstract][Full Text] [Related]
13. Antibody-antigen complex formation following injection of OC125 monoclonal antibody in patients with ovarian cancer.
Haisma HJ; Battaile A; Stradtman EW; Knapp RC; Zurawski VR
Int J Cancer; 1987 Dec; 40(6):758-62. PubMed ID: 3480271
[TBL] [Abstract][Full Text] [Related]
14. [Basic study for immunoscintigraphy of ovarian cancer using 99mTc labeled F(ab')2 fragments of monoclonal antibody].
Sugiyama S
Kaku Igaku; 1994 Apr; 31(4):327-36. PubMed ID: 8196229
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of CA 125 assay system and its diagnostic significance in gynecologic tumors].
Shimizu Y; Akagaki E; Hirota K; Kono M; Miura S; Okudaira Y
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2813-20. PubMed ID: 3866801
[TBL] [Abstract][Full Text] [Related]
16. Characterisation and clinical usefulness of CA130 antigen recognised by monoclonal antibodies, 130-22 and 145-9, in ovarian cancers.
Kobayashi H; Ohi H; Fujii T; Terao T
Br J Cancer; 1993 Feb; 67(2):237-43. PubMed ID: 7679280
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical localization of CA130 in fetal tissues, and in normal and neoplastic tissues of the female genital tract.
Nanbu Y; Fujii S; Konishi I; Nonogaki H; Sagawa N; Kobayashi F; Mori T; Saga T; Endo K
Asia Oceania J Obstet Gynaecol; 1990 Dec; 16(4):379-87. PubMed ID: 2099733
[TBL] [Abstract][Full Text] [Related]
18. Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma.
Sekine H; Hayes DF; Ohno T; Keefe KA; Schaetzl E; Bast RC; Knapp R; Kufe DW
J Clin Oncol; 1985 Oct; 3(10):1355-63. PubMed ID: 2413181
[TBL] [Abstract][Full Text] [Related]
19. [A new monoclonal antibody (SH-9) recognizes the low molecular mass of ovarian cancer antigen CA125].
Maeda H; Imai S; Morimoto J; Kiyozuka Y; Noda T; Haga S; Hiroishi S
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Apr; 42(4):320-6. PubMed ID: 1694212
[TBL] [Abstract][Full Text] [Related]
20. Idiotypic cascades after injection of the monoclonal antibody OC125: a study in a mouse model. Induction of antibodies against OC125 and CA125 after immunization with an anti-CA 125 (MAb OC125) monoclonal antibody by activation of the idiotypic network.
Schultes BC; Reinsberg J; Schlebusch H; Oehr P; Biersack HJ; Krebs D; Wagner U
Eur J Clin Chem Clin Biochem; 1993 Jul; 31(7):427-32. PubMed ID: 8399782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
